Performance of the pharmacy and therapeutics committee in a teaching hospital

Abstract

The hospital activities are characterized by a highly dynamism as a result of new health technologies such as medicines. A hospital due its characteristics of teaching, research and high complexity care, has the highest concentration of different types of health technologies. The Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto – USP (HCFMRP-USP) is a hospital, with proven quality, inserted in the SUS as a tertiary/quaternary referral and has the Pharmaceutical Services Division (DAF) for development of actions of health care. To aid resource management, selection and standardizationof drugs, DAF adopted the strategy of Pharmacy and Therapeutics Committee (CFT). The CFT is a collegial, consultative and deliberative body, established by the World Health Organization as a strategy tool to monitor and promote the quality in the use of medicine, but studies of CFTs are incipient in Brazil. Thus, this study aims to present the CFT of HCFMRP–USP. Objectives: To introduce the composition, responsibilities and working methods of CFT, as well as a critical analysis of its current operation. Methods: A descriptive study aimed to describe the current functioning of the CFT of HCFMRP-USP was performed. Ordinances, internal regulations were surveyed and a bibliographic review of the CFT was performed. To the critical analysis of the current operating, was selected by the committee from the standard one that would fit classification as belonging to “A” and “V” items after the crossing of the curves ABC and VEN, whose selected item was the medicine Sevoflurane. Results: The CFT was established in 2010 to replace the defunct standardization committee. Since then, the CFT examined 134 requests and 41 of these were standardized. The Sevoflurane drug was incorporated into the HCFMRP-USP in 2010 and, starting that year, there was a gradual increase in the consumption of the same. However, after analyzing the requirements of the drug in 2012, it was observed that the dispensation of Sevoflurane does not follow the specifications of the patient profile as established in the protocol established at the time of standardization. Conclusions: We concluded that the implementation of CFT was a strategy that provided a rational standardization. However, it is observed that there is no control of dispensing and use of the product according to the protocol established at the time of standardization. We emphasize that control the use of Sevoflurane is not responsibility of the CFT and this assignment should be delegated to the responsible technical area.